rs763348222
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3
The NM_004369.4(COL6A3):c.6898G>A(p.Gly2300Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000242 in 1,614,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G2300E) has been classified as Uncertain significance.
Frequency
Consequence
NM_004369.4 missense
Scores
Clinical Significance
Conservation
Publications
- Bethlem myopathy 1AInheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
- collagen 6-related myopathyInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
- Ullrich congenital muscular dystrophy 1CInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- dystonia 27Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
- Ullrich congenital muscular dystrophy 1AInheritance: AR, AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL6A3 | NM_004369.4 | c.6898G>A | p.Gly2300Arg | missense_variant | Exon 29 of 44 | ENST00000295550.9 | NP_004360.2 | |
| COL6A3 | NM_057167.4 | c.6280G>A | p.Gly2094Arg | missense_variant | Exon 28 of 43 | NP_476508.2 | ||
| COL6A3 | NM_057166.5 | c.5077G>A | p.Gly1693Arg | missense_variant | Exon 26 of 41 | NP_476507.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL6A3 | ENST00000295550.9 | c.6898G>A | p.Gly2300Arg | missense_variant | Exon 29 of 44 | 1 | NM_004369.4 | ENSP00000295550.4 | ||
| COL6A3 | ENST00000472056.5 | c.5077G>A | p.Gly1693Arg | missense_variant | Exon 26 of 41 | 1 | ENSP00000418285.1 | |||
| COL6A3 | ENST00000353578.9 | c.6280G>A | p.Gly2094Arg | missense_variant | Exon 28 of 43 | 5 | ENSP00000315873.4 | |||
| COL6A3 | ENST00000491769.1 | n.1152G>A | non_coding_transcript_exon_variant | Exon 6 of 20 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000637 AC: 16AN: 251284 AF XY: 0.0000957 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461856Hom.: 0 Cov.: 32 AF XY: 0.0000399 AC XY: 29AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74486 show subpopulations
ClinVar
Submissions by phenotype
Bethlem myopathy 1A Pathogenic:1Uncertain:1Benign:1
The NM_004369.4:c. 6898G>A, is a missense variant in the exon 29 of COL6A3 gene which is predicted to result in change in amino acid Glycine to Arginine in position 2300 in the polypeptide chain. This amino acid change leads to a deleterious effect on the protein as per computational prediction tools (aggregate score Revel - 0.712) (PMID: 36413997) (PP3 – Pathogenic Supporting). This variant was identified in an 8-year-old male child with suspected congenital myopathy with normal CPK levels. He had no contractures. The same variant was identified in a heterozygous state in his unaffected mother. This variant has an allele frequency of 0.00002416 in gnomAD v4.1.0 and 0.0002306 in South Asians (PM2 – Pathogenic Moderate). In summary, this variant meets criteria to be classified as variant of uncertain significance based on the ACMG/AMP criteria applied, as specified by PP3 & PM2 criteria. -
- -
- -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at